<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02410980</url>
  </required_header>
  <id_info>
    <org_study_id>NIH/LAMMP-Unilever-2014-1508</org_study_id>
    <nct_id>NCT02410980</nct_id>
  </id_info>
  <brief_title>Assessing the Effects of Tretinoin Cream on Human Skin With Optical Imaging Technologies</brief_title>
  <official_title>In-vivo Non-invasive Skin Imaging Pilot Study to Assess the Effects of Tretinoin Cream Using Multi-photon Microscopy and Multi-spectral Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Unilever R&amp;D</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beckman Laser Institute University of California Irvine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The researchers will assess the effects of treatment with tretinoin cream on human skin by
      using non-invasive optical imaging technologies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The researchers will evaluate changes in the dermis and skin properties as the effect of
      treatment with Tretinoin cream (0.1%) by using the following optical imaging techniques.

        1. Multiphoton microscopy using a clinical tomograph (MPTflex, Jenlab, Germany)

        2. Multispectral Imaging using a device developed at Beckman Laser Institute, UC Irvine
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Skin Collagen/Elastin ratio over time - Change from baseline in sun exposed, and non sun exposed skin areas.</measure>
    <time_frame>up to 2 months</time_frame>
    <description>The effects of tretinoin cream on human skin will be measured.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Collagen Fibril Alteration</condition>
  <arm_group>
    <arm_group_label>Tretinoin cream 0.1%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Assessment of the skin change</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tretinoin cream 0.1%</intervention_name>
    <description>Assessment of the skin change</description>
    <arm_group_label>Tretinoin cream 0.1%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female 45 years of age or older - Skin type scale I to III

        Exclusion Criteria:

          -  Large amount of dark, coarse hair on the arms

          -  History of allergies to alpha hydroxy acids (AHAs), retinoids, soaps, fragrances,
             sunscreens or Latex

          -  Currently using over-the-counter AHA or retinol within one month or prescription
             retinoid within three months of the start of the study.

          -  History of skin cancer, including squamous or basal cell carcinoma at the treatment
             site or history of malignant melanoma.

          -  History of diabetes

          -  Currently pregnant or nursing
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mihaela Balu, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beckman Laser Institute, UCI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beckman Laser Institute Medical Clinic</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2015</study_first_submitted>
  <study_first_submitted_qc>April 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2015</study_first_posted>
  <last_update_submitted>March 3, 2017</last_update_submitted>
  <last_update_submitted_qc>March 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Irvine</investigator_affiliation>
    <investigator_full_name>Beckman Laser Institute and Medical Center</investigator_full_name>
    <investigator_title>Mihaela Balu, Ph.D. Associate Specialist</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tretinoin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

